PLEGRIDY sol inj 125 mcg/0.5 ml ser pré 2 pce

7680682800018 CH-68280 L03AB13 01.99.0.
PLEGRIDY sol inj 125 mcg/0.5 ml ser pré 2 pce
PLEGRIDY sol inj 125 mcg/0.5 ml ser pré 2 pce
PLEGRIDY sol inj 125 mcg/0.5 ml ser pré 2 pce
1 / 3
google

Details

Product number
6828001
CPT
-
Packaging group
2
Unit
Fertigspritze(n)
Composition
peginterferonum beta-1a 125 µg, arginini hydrochloridum, natrii acetas trihydricus corresp. natrium 0.13 mg, acidum aceticum glaciale, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml.

Articles (1)

Plegridy 125 mcg/0.5 ml, Injektionslösung in einer Fertigspritze zur intramuskulären Anwendung
Injektionslösung
2
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
14/05/2024
Patient information leaflet
Français
14/05/2024
Patient information leaflet
Italien
14/05/2024

Detailed composition

Substance Quantity Type Category
(N/A)
125.0 UG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
0.13 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 924.15
Specialties list
Yes
Generic
No
SL addition date: 01/05/2022

Authorization holder

Biogen Switzerland AG

6340 Baar

Authorization information

Swissmedic authorization number
68280
Drug name
Plegridy, Injektionslösung in einer Fertigspritze zur intramuskulären Anwendung
Galenic form
INLFS
ATC Code
L03AB13
Authorization status
Z
Dispensation category
B
First authorization
01/03/2022
Authorization expiration date
28/02/2027
IT number
01.99.0.
Domain
Human medicine
Field of application
Multiple Sklerose

Packaging details

Description (FR)
PLEGRIDY sol inj 125 mcg/0.5 ml ser pré 2 pce
Description (DE)
PLEGRIDY Inj Lös 125 mcg/0.5 ml Fertspr 2 Stk
Market launch
01/03/2022
Narcotic (BTM)
No